Skip to main content

Which Hair Loss Procedures Do Dermatologists Use?

Which in-office procedures do dermatologists use for hair loss?

Most people walk into a hair loss appointment expecting a needle, and the first thing that actually happens is a magnified look at the scalp. That order isn't a formality, because a scarring alopecia needs the inflammation shut down while pattern loss needs the follicles stimulated, and treating one like the other burns months you can't get back. Everything on offer sits on a ladder, from a five-minute diagnostic look to an operating room.

Diagnostic Layer: Dermatoscope at 10x to 70x, a gentle pull test, standardized photographs, and a 4 mm punch biopsy when the picture is unclear.
This is the step that decides whether the goal is regrowth or simply stopping further destruction.
Injectable Layer: Intralesional triamcinolone at 2.5 to 10 mg per mL for patchy autoimmune loss, or platelet-rich plasma spun from your own blood across a thinning zone.
Stimulation Layer: Microneedling at 0.5 to 1.5 mm, in-office laser and LED panels, and topical immunotherapy for autoimmune loss that shrugged off injections.
Surgical Layer: Follicular unit extraction or strip harvesting, offered only once donor supply is adequate and the pattern has stopped moving.
What Matters Most

Every in-office hair loss procedure is layered on top of daily medical therapy rather than replacing it, which is why the dermatoscope exam at 10x to 70x magnification comes before anything is injected or transplanted.

What does an in-office corticosteroid injection do for patchy hair loss, and how often is it repeated?

Injected steroid works by shutting down the immune attack right where it's happening, which makes it the first-line move for patchy alopecia areata and a waste of a needle for pattern thinning. You're trading the whole-body burden of oral steroids for a drug delivered exactly where the inflammation sits. What you're not buying is a cure, since the autoimmune tendency stays put and a regrown patch can relapse once the local effect wears off.

  • Concentration: Triamcinolone at 2.5 to 10 mg per mL, the lower end for eyebrows and face.
  • Injection Grid: Roughly 0.05 to 0.1 mL per point, spaced about one centimeter apart.
  • Session Cap: Most guidelines hold total steroid near 20 mg per visit.
  • Depth Discipline: Stay in the deep dermis, since fat atrophy causes that shallow dent.
Field Note

Intralesional triamcinolone injections repeat every four to six weeks, with regrowth typically visible after the second or third round, and six months of properly dosed sessions without response signals that the diagnosis needs revisiting.

How are platelet-rich plasma injections prepared and delivered during a scalp appointment?

The appointment starts at your arm, not your scalp, and runs about 45 to 75 minutes end to end. The part that decides your result is the part you never see: spin speed, spin time, tube system and whether white cells are kept all change what ends up in the syringe, which is a big reason published outcomes disagree so much.

  1. Draw: 10 to 60 mL of whole blood into tubes containing an anticoagulant.
  2. Spin: A single spin yields a weaker concentrate, a double spin a tighter buffy coat fraction.
  3. Load: 3 to 8 mL of concentrate, ideally three to five times your baseline platelet level.
  4. Numb: Topical or ring block, sometimes a nerve block at the supraorbital and occipital nerves.
  5. Inject: A grid across the thinning zone, 0.05 to 0.1 mL per point about one centimeter apart, a few millimeters into the dermis where the follicular bulge sits.
Best Practice

A platelet-rich plasma course runs three to four monthly sessions followed by a reassessment photograph at six months and maintenance every four to six months, and it's ruled out by active scalp infection, platelet disorders, anticoagulant therapy or a scarring alopecia diagnosis.

What role does microneedling play in a dermatologist's hair loss toolkit?

Needling gets sold as a treatment and earns its keep as an amplifier. Hundreds of fine punctures create controlled micro-injuries that release growth factors, switch on Wnt signaling and pull blood supply toward follicles that had gone quiet. On its own that's a modest effect, but paired with a topical it's why the combination arms in the trials pulled ahead on hair count.

  • Device: A motorized pen or fixed-depth stamp, never a roller that drags and tears skin.
  • Depth: 0.5 to 1.5 mm reaches the dermal papilla without hitting subcutaneous tissue.
  • Timing: Hold the alcohol-based topical until the next day to limit irritation and absorption.
  • Hard Stop: Never needle over an active scarring alopecia, which worsens the problem being treated.
The Practical Move

Microneedling on the scalp is delivered at depths of 0.5 to 1.5 mm in weekly sessions combined with topical minoxidil, and those combination protocols consistently beat the topical alone on hair count by a meaningful margin.

When does a dermatologist recommend surgical hair restoration instead of a nonsurgical procedure?

There's a point where no amount of injecting helps, and it arrives when there are no follicles left to rescue. Everything nonsurgical acts on miniaturizing hairs that still exist, while surgery moves hair you already have from the back of your head to the front. Three things have to line up before a good surgeon will operate: adequate donor supply, a pattern that has stopped moving, and a diagnosis that isn't scarring.

Criteria Nonsurgical Procedures Surgical Restoration
Acts on Living, miniaturizing follicles Bald ground, using redistributed hair
Prerequisite Follicles still present in the zone Donor density near 65 to 85 units per sq cm
Timing Any stage, including active loss Pattern stable, usually a year on medication
Result window Judged at six to twelve months Sheds first, regrowth at month three to six
Ongoing need Repeat and maintenance sessions Continued medication or a second operation
The Trade-Off

Surgical hair restoration requires a permanent donor fringe of roughly 65 to 85 follicular units per square centimeter and a pattern stable for at least a year, and an active scarring alopecia must stay quiet for two years before anyone considers operating.

Which in-office procedures are diagnostic rather than therapeutic?

A large share of a hair loss visit is measurement rather than treatment, and it's the part people are most tempted to rush past. Skipping it is how you end up paying for a procedure aimed at the wrong disease.

  1. Trichoscopy: Under 10x to 70x, shaft diameter diversity above about 20 percent points toward androgenetic alopecia, while yellow dots and exclamation mark hairs point toward alopecia areata.
  2. Pull Test: Grasp 40 to 60 hairs near the scalp with steady traction; more than 10 percent releasing, roughly four to six hairs, suggests active shedding.
  3. Blood Panel: Ferritin, thyroid function, vitamin D and complete blood count, plus androgen levels in women with pattern loss and other signs.
  4. Standardized Photography: Fixed angles under fixed lighting, the only reliable way to judge nine months later whether a treatment worked.
  5. Punch Biopsy: Two 4 mm punches from an active affected edge, one sectioned horizontally and one vertically, when trichoscopy is ambiguous or scarring is suspected.
Worth Knowing

Trichoscopy, the hair pull test, blood work, standardized global photography and the 4 mm punch biopsy are diagnostic rather than therapeutic, and loss of follicular openings with perifollicular scale or redness signals a scarring process.

What is topical immunotherapy and which patients are treated with it?

This one sounds wrong the first time you hear it, because the treatment is a deliberate allergy on your scalp. A patch is sensitized with a 2 percent solution, then weekly applications start around 0.00001 to 0.001 percent and get dialed up until you hold a mild pink, faintly itchy dermatitis, and that controlled reaction appears to pull immune attention away from the follicle. It stays in specialist hands because the sensitizers are unstable in light, have to be compounded, and need staff trained not to sensitize themselves.

You have alopecia areata over more than half your scalp: This is the intended patient, and only after intralesional steroids have already failed.
You have alopecia totalis or universalis: Still a candidate, though very long-standing total loss and childhood onset both predict a weaker result.
You have a few small patches or pattern thinning: Wrong tool. Limited patches answer to injections, and pattern loss isn't autoimmune, so there's no attack here to distract.
How Pros Do It

Topical immunotherapy with diphenylcyclopropenone or squaric acid dibutyl ester is reserved for extensive alopecia areata after intralesional steroids fail, and roughly 30 to 60 percent of treated patients achieve cosmetically useful regrowth.

How strong is the published evidence behind the most common in-office hair loss procedures?

The honest picture is uneven, and knowing where it's thin protects you better than a blanket endorsement does. Two structural problems flatter results across the whole field: trials measure different things, from hairs per square centimeter to unblinded satisfaction scores, and a photograph can manufacture a visible difference through lighting, wet versus dry hair and haircut length with no biological change at all.

Well established: Intralesional corticosteroid for alopecia areata, with decades of clinical use and consistent guideline support.
Ironically few large randomized trials, because it became standard practice before that standard existed.
Reasonably supported: Low-level laser devices, which hold regulatory clearance for pattern hair loss and have several sham-controlled randomized trials behind them.
Mixed and messy: Platelet-rich plasma, with dozens of small studies, mostly split-scalp designs, and almost no two using the same preparation protocol.
Meta-analyses lean toward a density gain but call the heterogeneity too high to state an effect size.
Thinly supported: Microneedling, nearly always studied in combination, alongside exosome and stem-cell injections that rest largely on case series.
Technical Verdict

Intralesional corticosteroid for alopecia areata and low-level laser therapy for pattern hair loss carry the strongest published support, while platelet-rich plasma trials often enroll fewer than 40 participants with inconsistent protocols, and exosome and stem-cell-derived injections are not approved for this indication.

What side effects and complications can these scalp procedures cause?

Most of what goes wrong after a scalp procedure is minor, self-limiting and predictable, which is exactly why the rare problems deserve to be named instead of buried in a consent form. Your scalp is highly vascular and richly innervated, so bleeding looks dramatic relative to what it means, and swelling that migrates down toward your forehead and eyelids overnight isn't an emergency. The ones that should get your attention have a completely different shape.

  • Expected: Soreness for one to three days, itching while healing, and a temporary shed after needling or transplant.
  • Call Same Day: Spreading warmth, pain worsening after day three, pus or fever means infection.
  • Permanent: A widened donor scar, see-through donor area, transected grafts, or a hairline set too low.
  • Higher Risk: Blood thinners, bleeding disorders, poorly controlled diabetes, keloid tendency, or recent isotretinoin.
Hard-Learned Lesson

Infection after a scalp procedure shows as spreading warmth, pain worsening after day three, pus or fever and needs same-day contact, while steroid-induced fat atrophy leaves a visible depression that usually fills back in over several months.

What does a course of in-office hair loss treatment typically cost and is any of it covered by insurance?

Insurers draw one line and it decides your whole bill: is this treating a disease or improving how you look? Diagnostic work and steroid injections for alopecia areata usually land on the covered side, because there's a medical diagnosis attached to them. Everything aimed at pattern hair loss usually lands on the other, and the number that catches people out isn't the first year.

Procedure Typical Quoted Cost Coverage
Visit, trichoscopy, biopsy, blood panel Standard medical billing Usually covered with a diagnosis
Steroid injection for alopecia areata Per-session medical billing Usually covered
Platelet-rich plasma 500 to 1,200 dollars per session Self-pay
Microneedling 150 to 400 dollars per session Self-pay
Surgical restoration 3 to 8 dollars per graft Self-pay
Value Verdict

A first-year platelet-rich plasma course of four to six sessions typically runs 2,500 to 6,000 dollars and a 2,000 graft surgical case runs 6,000 to 16,000 dollars, both generally self-pay, while generic topical minoxidil and an oral antiandrogen cost a few hundred dollars a year with far stronger evidence.

How do in-office procedures fit alongside daily at-home treatment?

Think of your daily routine as the floor and the procedures as the ceiling. Pattern hair loss runs on an ongoing hormonal process that no single appointment interrupts, so the medication is the part holding everything else up. Take the floor away and the ceiling comes down with it.

The Foundation: Topical minoxidil once or twice daily, or oral low-dose minoxidil where appropriate, plus an antiandrogen such as finasteride or dutasteride in men and spironolactone or a similar agent in women.
Starting minoxidil often triggers an early shedding phase, so begin it a couple of months ahead of an injection course or the shed gets blamed on the procedure.
The Add-On: In-office injections, needling and transplantation, which supply the stimulation, absorption or redistribution medication alone can't.
The Extras: Home laser caps, supplements and rollers, worth adding once the evidence-backed core is in place and never worth substituting for it.
Worth Understanding

Gains from in-office procedures hold only while daily medical therapy continues, and a combined plan needs six to twelve months before it can be honestly judged because the hair cycle doesn't move faster than that.

Daniel Zengel
Written by Daniel Zengel
Medical Writer
Daniel Zengel is the principal owner of H-SHOT and a medical writer covering platelet-rich plasma and hair restoration. He draws on more than a decade in pharmaceutical and medical device roles, with a focus on regenerative medicine and the device standards and provider training that make PRP results consistent from clinic to clinic.